Investing Profile
Charles Dunn
Your Intro Paths to Charles Dunn
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Charles is a member of
Hotmail Network
4899 CONNECTIONS
Deloitte Network
310 CONNECTIONS
Deloitte Network
310 CONNECTIONS
Deloitte Network
310 CONNECTIONS
UCL Network
104 CONNECTIONS
Current Investing Position
SV Health Investors Principal
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Current Fund Size
£200M
Charles Dunn is on these Sector & Stage Rankings
Charles Dunn's Experience
Associate (Entrepreneurial Business) DeloittePresent
Senior Associate (Entrepreneurial Business) DeloittePresent
Assistant Manager DeloittePresent
Investment Analyst SV Health InvestorsPresent
Board Observer Autifony TherapeuticsPresent
Board Observer HotmailPresent
Investment Associate SV Health InvestorsPresent
Board Observer & Founding Team Mestag TherapeuticsPresent
Board Observer PulmocidePresent
Board Observer Imbria PharmaceuticalsPresent
Board Observer Enara BioPresent
Senior Investment Associate SV Health InvestorsPresent
Vice President SV Health InvestorsPresent
Member Board of Directors Mestag TherapeuticsPresent
Member Board of Directors Imbria PharmaceuticalsPresent
Principal SV Health InvestorsPresent
Member Board of Directors Draig TherapeuticsPresent
Member Board of Directors & Founding Investor Draig TherapeuticsPresent
Charles Dunn's Education
UCL MSci, Human/Medical Genetics Human/Medical Genetics
Investors who invest with Charles Dunn
Founders who looked at Charles Dunn's profile also looked at these Scouts & Angels